Valbona Mirakaj

Head of Division of Molecular Intensive Care Medicine

Eberhard Karls Universität Tübingen

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Valbona Mirakaj is the Head of the Division of Molecular Intensive Care Medicine at Eberhard Karls Universität Tübingen, Germany. Her research areas include mesenchymal stem cell therapy, inflammation resolution, and the implications of SARS-CoV-2 infection on the cardiovascular and respiratory systems. Recent publications have focused on the role of neuronal guidance proteins in cardiovascular inflammation and the predictive value of early driving pressure changes in ECMO outcomes for Acute Respiratory Distress Syndrome.

Articles (7)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Marius Keller

University Hospital Tübingen

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Valbona Mirakaj

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Neuronal guidance proteins in cardiovascular inflammation

Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS.

Sema7A is crucial for resolution of severe inflammation.

Severe SARS-CoV-2 infection inhibits fibrinolysis leading to changes in viscoelastic properties of blood clot: A descriptive study of fibrinolysis.

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.

Early Driving Pressure Changes Predict Outcomes during Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome.

Novel Resolution Mediators of Severe Systemic Inflammation.

Collaborators (1)

Marius Keller

Make your next move.